Proud to have co-authored this print article about expert patient contributions as educators, advocates, and research partners! Thanks to Collaboration for Outcomes using Social Media in Oncology (COSMO) for the opportunity.
You can read the full article online here: https://ascopubs.org/doi/full/10.1200/OP.21.00763
The IASLC STARS program invites STARS alumni and anyone interested in cancer research advocacy to join us for a webinar about cancer drug development.
When: Monday August 29, 2022, at 11:00AM Eastern Time
Title: Advocacy Opportunities in Cancer Drug Development and Regulatory Approval
Speakers: Upal Basu Roy, PhD, MPH,
Executive Director of Research, LUNGevity Foundation
Janet Freeman-Daily, MS, Eng
cancer research advocate and STARS staff (moderator)
Languages: English, with transcript translated into Spanish after the event
Learning objectives:
Register (it’s FREE) at https://us06web.zoom.us/webinar/register/WN_EmO7XBH6SdqDgHfDA0DLQQ
After registering, you will receive a confirmation email containing information about joining the webinar.
Reach out to advocacy@iaslc.org for more information.
The International Association for the Study of Lung Cancer (IASLC) offers webinars, training and networking opportunities to lung cancer research advocates through its Supportive Training for Advocates in Research and Science (STARS) program. Thank you to our STARS partner Research Advocacy Network and our 2022 STARS sponsors Lilly, Bayer, BMS, and Genentech for supporting this event!
This presentation was given on April 6, 2022, by Janet Freeman-Daily (a lung cancer patient research advocate) at the IASLC 2022 World Conference on Lung Cancer (#WCLC22) in Vienna, Austria during the “Social Media + Communications Workshop.”
Gray Connections 